Compare RCMT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCMT | RPID |
|---|---|---|
| Founded | 1971 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.0M | 204.3M |
| IPO Year | 1997 | 2021 |
| Metric | RCMT | RPID |
|---|---|---|
| Price | $25.55 | $1.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $36.00 | $8.00 |
| AVG Volume (30 Days) | 76.4K | ★ 154.2K |
| Earning Date | 04-03-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.38 | 2.78 |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $186,737,000.00 | $33,587,000.00 |
| Revenue This Year | $11.89 | $19.12 |
| Revenue Next Year | $12.46 | $18.42 |
| P/E Ratio | $48.21 | ★ N/A |
| Revenue Growth | 5.83 | ★ 19.74 |
| 52 Week Low | $17.26 | $1.81 |
| 52 Week High | $32.50 | $4.94 |
| Indicator | RCMT | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 57.87 | 30.64 |
| Support Level | $17.77 | N/A |
| Resistance Level | $27.62 | $2.46 |
| Average True Range (ATR) | 0.98 | 0.13 |
| MACD | 0.48 | -0.01 |
| Stochastic Oscillator | 100.00 | 3.66 |
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.